ESMO WCGIC 2023 | Early detection and diagnosis of pancreatic cancer

Philip Philip, MD, PhD, FRCP, Wayne State University School of Medicine/Henry Ford Health, Detroit, MI, comments on the latest developments in testing for pancreatic cancer. Early detection of high-risk pancreatic cancer is critical for patient outcomes, and certain risk factors can help identify patients who are at risk. Patients with a family history of cancer, carry certain genes such as BRCA1/2, and have onset diabetes have a higher probability of developing pancreatic cancer. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.